Middle East & Africa dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

The Middle East & Africa dPCR and qPCR market was valued at US$ 359.30 million in 2022 and is expected to reach US$ 504.97 million by 2030; it is estimated to grow at a CAGR of 4.3% from 2022 to 2030.

Development of Droplet Digital PCR Drives Middle East & Africa dPCR and qPCR Market

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, development of ddPCR would become a major trend in the Middle East & Africa dPCR and qPCR market in the future.

Middle East & Africa dPCR and qPCR Market Overview

The Middle East & Africa dPCR and qPCR market in the Middle East & Africa is segmented into UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience a significant growth due to increase in developments of varied reagent systems and automated systems in this region, introduction of a wide range of new products in diagnostic laboratories, and growing number of conferences, meetings, workshops and symposiums is expected to grow the molecular diagnostics awareness market in Middles East & Africa region.

Middle East & Africa dPCR and qPCR Market Segmentation

The Middle East & Africa dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Middle East & Africa dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Middle East & Africa dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Middle East & Africa dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Middle East & Africa dPCR and qPCR market is segmented into segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Middle East & Africa dPCR and qPCR market is segmented into segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa dPCR and qPCR market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa dPCR and qPCR market.